Načítá se...
Are there different evidence thresholds for genomic vs. clinical precision medicine? A VOI-based framework applied to antiplatelet drug therapy
OBJECTIVE: To evaluate evidence thresholds for clinically-guided precision medicine (PM) vs. genomically-guided PM. METHODS: We develop an “evidence threshold criterion” (ETC) that is the time-weighted difference between expected value of perfect information (EVPI) and incremental net health benefit...
Uloženo v:
| Vydáno v: | Value Health |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6746330/ https://ncbi.nlm.nih.gov/pubmed/31511188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jval.2019.03.023 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|